Related Experiment Video

Updated: Jun 11, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma

Claudia Papewalis1, Christiane Kouatchoua, Margret Ehlers

  • 1Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Germany. claudia.papewalis@uni-duesseldorf.de

Molecular and Cellular Endocrinology
|July 6, 2010
PubMed

Insights

Chromogranin A (CgA) peptide immunotherapy effectively generated a cytotoxic immune response against experimental malignant pheochromocytoma in mice, reducing tumor growth. This indicates CgA

Area of Science:

  • Immunology
  • Oncology
  • Endocrinology

Background:

  • Malignant pheochromocytoma lacks effective treatments.
  • Chromogranin A (CgA) is a potential target for cancer immunotherapy.

Purpose of the Study:

  • To investigate CgA peptide-based immunotherapy in a murine model of pheochromocytoma.
  • To assess the induction of a specific cytotoxic T cell (CTL) response against pheochromocytoma.

Main Methods:

  • Dendritic cell vaccination using modified and non-modified CgA peptides in 50 mice.
  • In vitro tetramer analysis to quantify CgA-specific CTLs.
  • Assessment of tumor infiltration by CD8+ T cells and tumor cell lysis capacity.

Main Results:

  • CgA vaccination significantly increased CgA-specific CTLs.
  • Vaccinated mice showed enhanced CD8+ T cell infiltration in tumors.
  • In vitro assays demonstrated MHC I-restricted lysis of pheochromocytoma cells by CTLs.
  • Significantly reduced liver tumor outgrowth was observed in treated mice.

Conclusions:

  • CgA peptide-based immunotherapy successfully induces a potent anti-tumor immune response in experimental pheochromocytoma.
  • This approach shows promise for treating malignant pheochromocytoma patients.

More Related Videos

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...